Galmed PharmaceuticalsEOCN

13F holders, Q1 2026 (March 31)
16holders −1
0new positions
0sold out
1famous investor
$0.49avg. 13F price*

At the end of Q1 2026, 16 institutions reported holding Galmed Pharmaceuticals Ltd. (EOCN) in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Two Sigma Investments, LP ($39K), XTX Topco Ltd ($11K) and Jane Street Group, LLC ($8K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Galmed Pharmaceuticals Ltd.
CUSIP
M47238148
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q3 2024: 10Q3 2024Q4 2024: 12Q4 2024Q1 2025: 13Q1 2025Q2 2025: 15Q2 2025Q3 2025: 14Q3 2025Q4 2025: 17Q4 2025Q1 2026: 16Q1 2026Q2 2026: 14Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q4 2025 → Q1 2026: 16,424 shares bought and 60,837 shares sold, net −44,413 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 16 holders

Two Sigma Investments, LP 0.00% Reduce -28.5% 80,177 $39K
XTX Topco Ltd 0.00% Add +102.7% 22,396 $11K
Jane Street Group, LLC 0.00% Add +35.5% 16,445 $8K
Two Sigma Securities, LLC 0.00% Reduce -12.0% 11,971 $6K
Citadel Advisors 0.00% Reduce -70.2% 11,382 $6K
UBS Group AG 0.00% Add +40.4% 2,546 $1K
BNP Paribas Financial Markets 0.00% Reduce -33.3% 600 $294
Morgan Stanley 0.00% Reduce -47.3% 157 $77
Wells Fargo & Company 0.00% Add +377.8% 43 $21
SBI Securities Co., Ltd. 0.00% No change 16 $8
Federation des caisses Desjardins du Quebec 0.00% No change 14 $7
Osaic Holdings, Inc. 0.00% No change 5 $2
Allworth Financial LP 0.00% No change 2 $1
Elevation Wealth Partners, LLC 0.00% No change 1 $1
Tsfg, LLC 0.00% No change 17 $0
Dogwood Wealth Management LLC 0.00% No change 1 $0

"% of holder's portfolio" is EOCN's weight in each manager's 13F, not the share of Galmed Pharmaceuticals Ltd. the manager owns.